SCHEMBL8547631

SCHEMBL8547631

CCN1c2ncccc2C(=O)N(C)c2ccc(-c3cc[nH]c3)nc21

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
BRD4 O60885 16/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8546643 0.85 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8701079 0.84 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8709305 0.83 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8545648 0.83 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8706528 0.82 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8551195 0.81 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8701594 0.81 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8548273 0.81 CCNC (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8701190 0.81 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8546272 0.81 ALDH1A1 (0.43) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 EP claimed
US-5837704-A PREVENTION OR TREATMENT OF AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-11-17 US disclosed
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 EP disclosed